Antibiotic Suspension pharma franchise in Goa

Antibiotic Suspension in PCD pharma franchise in Chennai

Antibiotic Suspension in top pharma company in Thane

Antibiotic Suspension in pcd pharma supplier in Bhopal

Antibiotic Suspension in phama franchise company in India
Antibiotic Suspension in phama distributor in Visakhapatnam

Home/Products /ofloxacin-50mg-ornidazole-125mg-racecadotril-15mg-suspension

About the Product

Description


Ofloglee O Suspension is a triple-action formulation combining Ofloxacin (50mg), Ornidazole (125mg), and Racecadotril (15mg) to provide comprehensive management for diarrhea and gastrointestinal infections. This unique combination targets infection, inflammation, and fluid loss, ensuring quick symptom relief and recovery.

  • Ofloxacin, a fluoroquinolone antibiotic, disrupts bacterial DNA synthesis, effectively treating a broad spectrum of bacterial infections.
  • Ornidazole, an antiprotozoal agent, combats anaerobic bacteria and protozoal infections, making it effective in mixed infections.
  • Racecadotril, an antidiarrheal agent, reduces excessive fluid secretion in the intestine, controlling diarrhea without affecting normal bowel movements.

This suspension is particularly useful in treating conditions such as infectious diarrhea, dysentery, and mixed bacterial and protozoal gastrointestinal infections. Its comprehensive approach ensures infection control and fluid balance while minimizing discomfort.

The liquid form allows for easy administration and precise dosing, making it ideal for both pediatric and adult patients. By combining antimicrobial and antidiarrheal properties, Ofloglee O Suspension ensures fast relief and prevents dehydration caused by diarrhea.

Common side effects include nausea, abdominal pain, dizziness, or a metallic taste. Rarely, allergic reactions such as rash or itching may occur.

Ofloglee O Suspension is indicated for treating infectious diarrhea, dysentery, mixed bacterial and protozoal infections, and acute gastroenteritis.

Use only under medical supervision. Complete the full course as prescribed to prevent recurrence or resistance. Avoid use in individuals with known allergies to any components of this formulation.

Store at a temperature below 25°C. Protect from sunlight and moisture. Shake well before each use and keep the bottle tightly closed.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ofloxacin 50mg + Ornidazole 125mg + Racecadotril 15mg Suspension in the PCD pharma franchise market?

This suspension has strong demand in the pediatric care, gastroenterology, and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diarrhea and intestinal infection management portfolios.

Why should medical distributors include this suspension in their product range?

Medical distributors and agencies can benefit from consistent demand for diarrhea and gastrointestinal infection management under medical supervision. Ofloxacin 50mg is a broad-spectrum antibiotic used against bacterial gastrointestinal infections Ornidazole 125mg is effective against protozoal and anaerobic infections Racecadotril 15mg is an antidiarrheal agent that reduces excessive intestinal fluid secretion without affecting gut motility Commonly prescribed for acute diarrhea, gastroenteritis, dysentery, mixed bacterial-protozoal infections, and pediatric diarrheal conditions as prescribed by physicians Provides triple action: infection control + reduction of intestinal secretion + faster recovery from diarrhea Widely prescribed by pediatricians, physicians, and gastroenterologists This strengthens a comprehensive gastrointestinal and pediatric anti-infective portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ofloxacin + Ornidazole + Racecadotril Suspension with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong pediatric and seasonal demand, repeat prescriptions, reliable supply chain support, and attractive margins in the gastrointestinal segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.